Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Effects of Qidi Tongbian Prescription on mice with slow transit constipation based on Wnt/β-catenin pathway
Hits 39  Download times 31  Received:March 04, 2024  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2024.09.17
Key Words   slow transit constipation;Qidi Tongbian Prescription;Wnt/β-catenin signaling pathway
Author NameAffiliationE-mail
WANG Jiali Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China  
LI Junxiang Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China  
SHI Lei Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China klmysl1205@126.com 
MAO Tangyou Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China  
CHEN Runhua Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China  
HAN Xiao Exchange, Development&Service Center for Science&Technology Talents, Beijing 100864, China  
ZHANG Xiaosi Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China  
HU Juncong Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China  
Abstract
    [Objective] To study the specific regulatory effects of Qidi Tongbian Prescription on slow transit constipation (STC) mice based on Wnt/β-catenin signaling pathway. [Methods] The 30 BALB/c mice were randomly divided into 6 groups,five mice in each group. Except the blank group,the STC mouse model was established by intragastric administration of loperamide hydrochloride (10 mg/kg) for 14 days,followed by intragastric intervention of high,medium and low doses(18.906,9.453,4.727 g/kg) of Qidi Tongbian Prescription and positive drug lactulose(3 g/kg) for 14 days. Fecal moisture content,fecal quantity and small intestine advancement rate were measured. Colon histological changes were evaluated by HE staining. Gene and protein expression levels of Wnt-3a and β-catenin were detected by PCR and immunohistochemistry. And the expression level of Ano1 protein in Cajal interstitial cells (ICC) was detected by immunofluorescence staining. The expression levels of Occludin,5-hydroxytryptamine(5-HT) and aquaporin 3(AQP3) were detected by ELISA. [Results] Compared with blank group,the small intestinal propulsion rate,fecal quantity and water content in model group were significantly decreased(P<0.01). The intervention of Qidi Tongbian Prescription could effectively improve the small intestinal propulsion rate,fecal quantity and water content(P<0.05),and improve the histological lesions. Compared with blank group,the expression of Wnt-3a,β-catenin mRNA(P<0.05) and protein(P<0.01) increased in model group,while the expression of Ano1 protein decreased(P<0.01),Occludin protein decreased(P<0.01). The protein expressions of AQP3(P<0.01) were increased. The prognosis showed that Wnt-3a protein,β-catenin mRNA and protein expression decreased(P<0.05),Ano1 protein expression increased(P<0.01),Occludin protein expression increased(P<0.01). The protein expressions of AQP3 were decreased(P<0.05). [Conclusion] Qidi Tongbian Prescription may play a role in the treatment of STC by inhibiting the overactivation of Wnt/β-catenin signaling pathway.

You are the 2310122 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.